Sexual dysfunction has a significant impact on quality of life, personal relationships, self-esteem, and recovery, and it is a common cause for nonadherence or discontinuation of medication.
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
We recently interviewed Jack Turban, MD, a resident physician in psychiatry at The Massachusetts General Hospital in Boston, where he researches the mental health of transgender youth.
A substantial body of research points to a multifaceted link between depression and cardiovascular disease, with rates of depression being 3 times higher in patients with coronary artery disease compared to the general population
We recently interviewed Jamieson Webster, PhD, and Victoria Malkin, PhD, LP, psychoanalysts based in New York who recently spent time on the frontlines of the COVID-19 pandemic in a Brooklyn hospital.
To dig deeper into the study and its importance for a growing field, we spoke with Laura H. Goldstein, PhD, of the Department of Psychology, King’s College London, United Kingdom.
As a result of stay-at-home restrictions and sudden unemployment, millions of people are isolated at home without their usual routines and supports, with a large amount of unstructured time on their hands, less opportunity to exercise and obtain healthy food, and increased stress.
For psychiatric professionals, Administrations of Lunacy offers a critical exploration of psychiatry’s historic links to key moments in American history by focusing on an asylum that was the largest in the world in the mid-20th century.
We recently interviewed Nancy Lau, PhD, to learn more about the state of smartphone applications for psychosocial wellness before COVID-19 and how the pandemic may affect digital technologies in health care.
When the spread of COVID-19 began to necessitate physical distancing, telemedicine was suddenly recast in many settings as the only option rather than just a feasible alternative to in-person care.
In this review, study authors discuss and summarize the current evidence for the evaluation and management of the most prevalent and well-described conditions in SCI, including impact of SCI on sleep and daytime function.
Presently, clinicians should be urged to view genetics as an additional tool in choosing prescriptions for MDD, as opposed to a replacement for complete clinical evaluation.
To shed light on how clinical practice is dealing in this time of COVID-19, we spoke with Jesse Clark, DO, Associate Program Director of Education at the Community East Family Medicine Residency and Clinical Chairperson of Family Medicine at Marian University College of Osteopathic Medicine, Indianapolis, Indiana.
In the long term, social isolation may well impose increased mortality risks on society’s most at-risk populations for mortality from cancer and cardiovascular disease, as well as from COVID-19.
Driven by the No Child Left Behind Act of 2001, school districts responded to pressures to increase school rankings and test scores by having more children tested for ADHD.
The CMS interim regulations are aimed at improving access to telemedicine and remote monitoring services in an effort to circumvent unnecessary exposure to COVID-19.
At a time when the healthcare system as a whole is in crisis—in the United States and around the world—Bedlam offers a critical perspective on the difficulty of providing care in a system stretched thin.
Deficits in reward processing are evident in several psychological disorders, including anxiety, substance abuse, personality disorders, attention-deficit/hyperactivity disorder, and psychotic disorders.
For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.
59% of Americans report that COVID-19 is affecting their daily lives, and 36% of respondents to the poll say that COVID-19 is taking a toll on their mental health.
Can mere light become a revolutionary new treatment for traumatic brain injury, posttraumatic stress disorder, depression, stroke, Parkinson disease, and Alzheimer disease?
Transparency about COI may actually exacerbate bias among both clinicians and patients alike; disclosure may simply transform a secret bias to an open bias, or may seemingly absolve a researcher of evident bias.
Recent shifts in studies of sex and gender reiterate the critical need to tailor mental health care to each patient and to remain mindful about assumptions regarding sex and gender and their role in a given patient’s specific challenges.
Investigators sought to determine whether there exists a mechanistic association between Alzheimer disease (AD) and depression, including whether progression of depressive symptoms is related to cognitive decline during beginning stages of AD or whether depression could predict risk of developing AD.
The COVID-19 epidemic has underscored potential gaps in mental health services during emergencies, while also testing the resilience of healthcare workers and medical systems.
Many older persons may have subthreshold depression, defined in the DSM-5 as depressed mood with at least 1 symptom of MDD and the presence of “clinically significant distress or deficit lasting at least 2 weeks.”
A new guideline from AAN offers recommendations on the use of behavioral, nutraceutical, and complementary and alternative medicine (CAM) for improving sleep disorders in children with ASD.
There is an emerging view that sleep disorders are not merely symptoms of psychiatric conditions; instead there may be a complex, bidirectional relationship between psychiatric and sleep disorders.
Responses to treatment depend on the target chosen, with 5 targets yielding positive outcomes, including the ventral anterior limb of the internal capsule, subthalamic nucleus, nucleus accumbens, ventral capsule/ventral striatum, or inferior thalamic peduncle, all involving fronto-striato-thalamocortical circuits.
Katlein França, MD, PhD, spoke with Dermatology Advisor about the use of the behavior therapy technique “habit reversal training” (HRT) for the treatment of trichotillomania, excoriation disorder, and itch.
